20 uñas engrosadas y frágiles.

Same author

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.

The British journal of dermatology·2021

Same author

The molecular pathogenesis of morphoea: from genetics to future treatment targets.

The British journal of dermatology·2016

Same author

Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters.

The British journal of dermatology·2016

Same author

Pseudoacromegalic facial features in Fabry disease.

Clinical and experimental dermatology·2012

Same author

Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.

The British journal of dermatology·2012

Same author

Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.

Clinical and experimental dermatology·2011

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

20 uñas engrosadas y frágiles.

Videos de Conceptos Relacionados

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.

The molecular pathogenesis of morphoea: from genetics to future treatment targets.

Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters.

Pseudoacromegalic facial features in Fabry disease.

Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.

Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

20 uñas engrosadas y frágiles.

Videos de Conceptos Relacionados

Artículos Relacionados

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.

The molecular pathogenesis of morphoea: from genetics to future treatment targets.

Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters.

Pseudoacromegalic facial features in Fabry disease.

Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.

Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.